ArticleInfectious diseases and therapy2026

Real-World Effectiveness of Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Pneumonia, Time-Stratified Risk Factors for Short- and Long-Term Mortality, and Inpatient Costs: A Multicenter Retrospective Cohort Study.

Chao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.